LUNG CANCER, NON-SMALL CELL
Clinical trials for LUNG CANCER, NON-SMALL CELL explained in plain language.
Never miss a new study
Get alerted when new LUNG CANCER, NON-SMALL CELL trials appear
Sign up with your email to follow new studies for LUNG CANCER, NON-SMALL CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo aims to keep lung cancer at bay after chemo
Disease control CompletedThis phase 3 trial tested whether adding niraparib (a drug that interferes with cancer cell repair) to pembrolizumab (an immunotherapy) helps keep advanced non-small cell lung cancer from progressing. The study enrolled 666 adults whose cancer had stabilized or shrunk after initi…
Matched conditions: LUNG CANCER, NON-SMALL CELL
Phase: PHASE3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New vaccine combo shows promise in advanced cancers
Disease control CompletedThis phase 2 trial tested a new cancer vaccine (IO102-IO103) combined with the immunotherapy drug pembrolizumab as a first treatment for people with advanced lung, head/neck, or bladder cancer that had spread. The study enrolled 63 participants to see if the combination is safe a…
Matched conditions: LUNG CANCER, NON-SMALL CELL
Phase: PHASE2 • Sponsor: IO Biotech • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC